Federated Hermes Portfolio holdings
AUM
$53.1B
1-Year Return
30.23%
This Quarter Return
+13.69%
1 Year Return
+30.23%
3 Year Return
+93.51%
5 Year Return
+187.87%
10 Year Return
+487.63%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.64B
Cap. Flow
% of AUM
4.97%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Top Buys
| 1 |
Zscaler
ZS
|
+$279M |
| 2 |
Palantir
PLTR
|
+$257M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$229M |
| 4 |
Broadcom
AVGO
|
+$221M |
| 5 |
FirstEnergy
FE
|
+$184M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
+$361M |
| 2 |
Philip Morris
PM
|
+$297M |
| 3 |
Gilead Sciences
GILD
|
+$209M |
| 4 |
Entergy
ETR
|
+$209M |
| 5 |
Paychex
PAYX
|
+$199M |
Sector Composition
| 1 | Technology | 22.9% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.27% |
| 5 | Consumer Discretionary | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
901
Employers Holdings
EIG
$982M
| $2.29M | ﹤0.01% |
48,542
+703
| +1% | +$33.2K |
|
902
Upbound Group
UPBD
$1.46B
| $2.29M | ﹤0.01% |
91,234
-210,857
| -70% | -$5.29M |
|
903
Kyndryl
KD
$7.49B
| $2.29M | ﹤0.01% |
54,571
+6,241
| +13% | +$262K |
|
904
Zymeworks
ZYME
$1.15B
| $2.29M | ﹤0.01% |
182,270
+358
| +0.2% | +$4.49K |
|
905
Peoples Bancorp
PEBO
$1.09B
| $2.29M | ﹤0.01% |
74,901
+2,353
| +3% | +$71.9K |
|
906
Constellation Energy
CEG
$100B
| $2.29M | ﹤0.01% |
7,085
+2,714
| +62% | +$876K |
|
907
Markel Group
MKL
$24.3B
| $2.28M | ﹤0.01% |
1,142
-362
| -24% | -$723K |
|
908
Enpro
NPO
$4.61B
| $2.27M | ﹤0.01% |
11,868
-444
| -4% | -$85K |
|
|
SAGE
909
DELISTED
Sage Therapeutics
SAGE
| $2.25M | ﹤0.01% |
246,804
-945,685
| -79% | -$8.62M |
|
910
Vanguard Total Stock Market ETF
VTI
$532B
| $2.25M | ﹤0.01% |
7,403
| – | – |
|
911
Mueller Industries
MLI
$10.8B
| $2.25M | ﹤0.01% |
28,310
-539
| -2% | -$42.8K |
|
912
Akebia Therapeutics
AKBA
$777M
| $2.25M | ﹤0.01% |
617,318
-296,131
| -32% | -$1.08M |
|
913
Macerich
MAC
$4.53B
| $2.24M | ﹤0.01% |
138,222
-263,059
| -66% | -$4.26M |
|
914
Fifth Third Bancorp
FITB
$30.1B
| $2.23M | ﹤0.01% |
54,273
-9,406
| -15% | -$387K |
|
915
Tarsus Pharmaceuticals
TARS
$2.29B
| $2.23M | ﹤0.01% |
55,021
+339
| +0.6% | +$13.7K |
|
916
CareDx
CDNA
$710M
| $2.23M | ﹤0.01% |
113,950
-17,911
| -14% | -$350K |
|
917
Manhattan Associates
MANH
$12.8B
| $2.21M | ﹤0.01% |
11,203
+1,024
| +10% | +$202K |
|
918
InMode
INMD
$949M
| $2.2M | ﹤0.01% |
152,233
-197
| -0.1% | -$2.85K |
|
919
NovoCure
NVCR
$1.37B
| $2.19M | ﹤0.01% |
123,072
-97,003
| -44% | -$1.73M |
|
920
TopBuild
BLD
$11.8B
| $2.19M | ﹤0.01% |
6,759
+654
| +11% | +$212K |
|
921
Antero Resources
AR
$10.1B
| $2.18M | ﹤0.01% |
54,020
-3,652
| -6% | -$147K |
|
922
ePlus
PLUS
$1.93B
| $2.14M | ﹤0.01% |
+29,719
| New | +$2.14M |
|
923
Kemper
KMPR
$3.32B
| $2.14M | ﹤0.01% |
33,170
+27,482
| +483% | +$1.77M |
|
924
Valaris
VAL
$3.75B
| $2.13M | ﹤0.01% |
50,609
+47,663
| +1,618% | +$2.01M |
|
925
Codexis
CDXS
$219M
| $2.13M | ﹤0.01% |
872,814
-215,137
| -20% | -$525K |
|